NO996440D0 - Omeprazol-natriumsalt - Google Patents
Omeprazol-natriumsaltInfo
- Publication number
- NO996440D0 NO996440D0 NO996440A NO996440A NO996440D0 NO 996440 D0 NO996440 D0 NO 996440D0 NO 996440 A NO996440 A NO 996440A NO 996440 A NO996440 A NO 996440A NO 996440 D0 NO996440 D0 NO 996440D0
- Authority
- NO
- Norway
- Prior art keywords
- sodium salt
- omeprazole sodium
- omeprazole
- salt
- sodium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702483A SE510643C2 (sv) | 1997-06-27 | 1997-06-27 | Termodynamiskt stabil omeprazol natrium form B |
PCT/SE1998/001124 WO1999000380A1 (en) | 1997-06-27 | 1998-06-11 | Omeprazole sodium salt |
Publications (3)
Publication Number | Publication Date |
---|---|
NO996440D0 true NO996440D0 (no) | 1999-12-23 |
NO996440L NO996440L (no) | 2000-02-08 |
NO318245B1 NO318245B1 (no) | 2005-02-21 |
Family
ID=20407555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19996440A NO318245B1 (no) | 1997-06-27 | 1999-12-23 | Omeprazol-natriumsalt |
Country Status (35)
Country | Link |
---|---|
US (1) | US6207188B1 (no) |
EP (2) | EP1186602A3 (no) |
JP (1) | JP3377218B2 (no) |
KR (1) | KR100580987B1 (no) |
CN (1) | CN1134432C (no) |
AR (1) | AR013350A1 (no) |
AT (1) | ATE233756T1 (no) |
AU (1) | AU750239B2 (no) |
BR (1) | BR9810483A (no) |
CA (1) | CA2294614C (no) |
CZ (1) | CZ296723B6 (no) |
DE (1) | DE69811892T2 (no) |
DK (1) | DK0991641T3 (no) |
EE (1) | EE03613B1 (no) |
EG (1) | EG24224A (no) |
ES (1) | ES2191944T3 (no) |
HK (1) | HK1026699A1 (no) |
HU (1) | HU227976B1 (no) |
ID (1) | ID24829A (no) |
IL (2) | IL133559A0 (no) |
IS (1) | IS1946B (no) |
MY (1) | MY127871A (no) |
NO (1) | NO318245B1 (no) |
NZ (1) | NZ501929A (no) |
PL (1) | PL190869B1 (no) |
PT (1) | PT991641E (no) |
RU (1) | RU2186778C2 (no) |
SA (1) | SA98190410B1 (no) |
SE (1) | SE510643C2 (no) |
SK (1) | SK283958B6 (no) |
TR (1) | TR199903270T2 (no) |
TW (1) | TW483758B (no) |
UA (1) | UA58556C2 (no) |
WO (1) | WO1999000380A1 (no) |
ZA (1) | ZA985317B (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
GB2324093A (en) | 1996-01-04 | 1998-10-14 | Rican Limited | Helicobacter pylori bacterioferritin |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
SE510643C2 (sv) | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
IL145220A0 (en) * | 1999-05-20 | 2002-06-30 | Par Pharmaceutical Inc | Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process |
SE9903831D0 (sv) | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
EP1706397A4 (en) * | 2000-05-15 | 2007-08-01 | Ranbaxy Lab Ltd | AMORPHOUS FORM OF OMEPRAZOLE SALTS |
DE60123800T2 (de) * | 2000-08-04 | 2007-10-11 | Takeda Pharmaceutical Co. Ltd. | Salze von benzimidazol-derivaten und deren verwendung |
EP1310252A4 (en) | 2000-08-18 | 2009-06-10 | Takeda Pharmaceutical | INJECTIONS |
EP1411900B2 (en) * | 2001-06-01 | 2013-12-04 | Pozen, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
KR100433735B1 (ko) * | 2001-06-27 | 2004-06-04 | 주식회사 씨트리 | 결정형 ⅰ을 갖는 란소프라졸의 제조방법 |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
AU2003278406A1 (en) * | 2002-10-22 | 2004-05-13 | Ranbaxy Laboratories Limited | Amorphous form of esomeprazole salts |
CN1842525A (zh) | 2003-05-05 | 2006-10-04 | 兰贝克赛实验室有限公司 | 苯并咪唑衍生物的钡盐 |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
FR2871800B1 (fr) * | 2004-06-17 | 2006-08-25 | Sidem Pharma Sa Sa | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique |
CA2570795C (en) * | 2004-06-24 | 2013-05-28 | Astrazeneca Ab | Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
WO2006073779A1 (en) * | 2004-12-30 | 2006-07-13 | Transform Phamaceuticals, Inc. | Novel omeprazole forms and related methods |
US8247566B2 (en) * | 2005-06-08 | 2012-08-21 | Lek Pharmaceuticals D.D. | Crystalline solvate of omeprazole sodium |
AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
CN101412710B (zh) * | 2008-12-16 | 2010-04-21 | 海南百那医药发展有限公司 | 一种奥美拉唑钠化合物及其制法 |
EP2445499A4 (en) | 2009-06-25 | 2013-02-27 | Astrazeneca Ab | METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE |
CN102638978A (zh) * | 2009-06-25 | 2012-08-15 | 波曾公司 | 用于治疗需要阿司匹林治疗之患者的方法 |
CN102351846B (zh) * | 2011-09-07 | 2012-08-22 | 周晓东 | 一种新的奥美拉唑钠化合物及其药物组合物 |
CN102319223B (zh) * | 2011-09-21 | 2013-06-19 | 石药集团欧意药业有限公司 | 一种埃索美拉唑冻干制剂及其制备方法 |
CN102512380B (zh) * | 2011-12-20 | 2013-04-17 | 海南锦瑞制药股份有限公司 | 一种以奥美拉唑钠为活性成分的冻干粉针剂及其制备方法 |
UA115139C2 (uk) | 2011-12-28 | 2017-09-25 | Поузен Інк. | Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту |
CN102827147B (zh) * | 2012-09-13 | 2013-08-07 | 山东罗欣药业股份有限公司 | 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物 |
CN102871973A (zh) * | 2012-10-16 | 2013-01-16 | 浙江亚太药业股份有限公司 | 一种奥美拉唑钠冻干制剂及其制备方法 |
CN103012371B (zh) * | 2013-01-05 | 2014-02-12 | 宁辉 | 奥美拉唑钠结晶化合物、其制备方法及其药物组合物 |
CN103570687B (zh) * | 2013-11-15 | 2015-01-07 | 悦康药业集团有限公司 | 一种奥美拉唑钠晶体化合物 |
CN104788426B (zh) * | 2015-04-02 | 2015-12-30 | 天津大学 | 一种奥美拉唑钠半水合物及其制备方法 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
CN116041325A (zh) * | 2022-12-09 | 2023-05-02 | 山东北大高科华泰制药有限公司 | 稳定化质子泵抑制剂的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2719916C2 (de) * | 1977-05-04 | 1987-03-19 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decanen |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
ES2023778A6 (es) * | 1990-12-12 | 1992-02-01 | Genesis Para La Investigacion | Procedimiento para preparar sales alcalinas del omeprazol |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
WO1995032957A1 (en) * | 1994-05-27 | 1995-12-07 | Astra Aktiebolag | Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles |
CZ289804B6 (cs) | 1994-07-08 | 2002-04-17 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma I |
SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
CN1042423C (zh) * | 1995-05-25 | 1999-03-10 | 常州市第四制药厂 | 奥美拉唑盐水合物及其制备方法 |
AU5982298A (en) * | 1997-03-07 | 1998-09-29 | A/S Gea Farmaceutisk Fabrik | Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos |
EP0968204A1 (en) * | 1997-03-07 | 2000-01-05 | A/S GEA Farmaceutisk Fabrik | Process for the preparation of 2- (2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose |
SE510643C2 (sv) | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
-
1997
- 1997-06-27 SE SE9702483A patent/SE510643C2/sv not_active IP Right Cessation
-
1998
- 1998-06-11 WO PCT/SE1998/001124 patent/WO1999000380A1/en active IP Right Grant
- 1998-06-11 HU HU0003017A patent/HU227976B1/hu not_active IP Right Cessation
- 1998-06-11 US US09/101,081 patent/US6207188B1/en not_active Expired - Lifetime
- 1998-06-11 ID IDW991685A patent/ID24829A/id unknown
- 1998-06-11 RU RU2000100361/04A patent/RU2186778C2/ru active
- 1998-06-11 PT PT98931166T patent/PT991641E/pt unknown
- 1998-06-11 ES ES98931166T patent/ES2191944T3/es not_active Expired - Lifetime
- 1998-06-11 AT AT98931166T patent/ATE233756T1/de active
- 1998-06-11 CN CNB988066165A patent/CN1134432C/zh not_active Expired - Lifetime
- 1998-06-11 EE EEP199900593A patent/EE03613B1/xx not_active IP Right Cessation
- 1998-06-11 NZ NZ501929A patent/NZ501929A/en not_active IP Right Cessation
- 1998-06-11 DK DK98931166T patent/DK0991641T3/da active
- 1998-06-11 AU AU81353/98A patent/AU750239B2/en not_active Expired
- 1998-06-11 IL IL13355998A patent/IL133559A0/xx active IP Right Grant
- 1998-06-11 BR BR9810483-7A patent/BR9810483A/pt not_active Application Discontinuation
- 1998-06-11 EP EP01128973A patent/EP1186602A3/en not_active Withdrawn
- 1998-06-11 TR TR1999/03270T patent/TR199903270T2/xx unknown
- 1998-06-11 JP JP50548499A patent/JP3377218B2/ja not_active Expired - Lifetime
- 1998-06-11 KR KR1019997012236A patent/KR100580987B1/ko not_active IP Right Cessation
- 1998-06-11 CZ CZ0469999A patent/CZ296723B6/cs not_active IP Right Cessation
- 1998-06-11 CA CA002294614A patent/CA2294614C/en not_active Expired - Lifetime
- 1998-06-11 DE DE69811892T patent/DE69811892T2/de not_active Expired - Lifetime
- 1998-06-11 SK SK1729-99A patent/SK283958B6/sk not_active IP Right Cessation
- 1998-06-11 EP EP98931166A patent/EP0991641B1/en not_active Expired - Lifetime
- 1998-06-11 PL PL337735A patent/PL190869B1/pl unknown
- 1998-06-15 TW TW087109498A patent/TW483758B/zh not_active IP Right Cessation
- 1998-06-16 AR ARP980102857A patent/AR013350A1/es active IP Right Grant
- 1998-06-18 ZA ZA985317A patent/ZA985317B/xx unknown
- 1998-06-24 EG EG74298A patent/EG24224A/xx active
- 1998-06-26 MY MYPI98002907A patent/MY127871A/en unknown
- 1998-08-19 SA SA98190410A patent/SA98190410B1/ar unknown
- 1998-11-06 UA UA99126959A patent/UA58556C2/uk unknown
-
1999
- 1999-12-16 IL IL133559A patent/IL133559A/en not_active IP Right Cessation
- 1999-12-21 IS IS5314A patent/IS1946B/is unknown
- 1999-12-23 NO NO19996440A patent/NO318245B1/no not_active IP Right Cessation
-
2000
- 2000-08-31 HK HK00105459A patent/HK1026699A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO996440D0 (no) | Omeprazol-natriumsalt | |
ATE260243T1 (de) | N-aroylphenylalaninderivate | |
ATE235220T1 (de) | Resorcinderivate | |
ID22781A (id) | Turunan-turunan nikotinamida | |
ATE284385T1 (de) | Sulfonamidderivate | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
DE69802569D1 (de) | Aufhängungseinrichtung | |
DE69825147D1 (de) | 2-amino-6-(2-substituierte-4-phenoxy)-substituierte-pyridine | |
ATE255098T1 (de) | Substituierte chromanderivate | |
DE69805807D1 (de) | Mikrobiozide n-sulfonylglycin-alkynyloxyphenethylamid-derivate | |
DE69841086D1 (de) | 5-Deoxy-Cytidin-Derivate | |
ATE255099T1 (de) | Substituierte chromanderivate | |
ID18027A (id) | Garam amina | |
DE69829682D1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate | |
NO995853D0 (no) | Nytt salt | |
ATE241275T1 (de) | Phosphoniumsalz-zusammensetzung | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
NO981495D0 (no) | Phenoxymetylpiperidin-derivater | |
DE69813264D1 (de) | Kleiderbügel | |
DK0966437T3 (da) | 5-Aroylnaphthalenderivater | |
DE69824255D1 (de) | Deformylase | |
DK1015447T3 (da) | Piperidinylmethyloxazolidinonderivat | |
DE69804153D1 (de) | Aufhänger | |
DE69814731D1 (de) | Kleiderbügel | |
FR2766076B1 (fr) | Cintre-presentoir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |